Comments
Loading...

Hims & Hers Health Analyst Ratings

HIMSNYSE
Logo brought to you by Benzinga Data
$36.16
3.069.24%
At close: -
$35.70
-0.46-1.27%
After Hours: 7:59 PM EDT
Q1 2025 Earnings in 3 days from now on Mon May 5th, after the market close
Conference call scheduled in 3 days at 17:00 PM Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$68.00
Lowest Price Target1
$6.00
Consensus Price Target1
$28.47

Hims & Hers Health Analyst Ratings and Price Targets | NYSE:HIMS | Benzinga

Hims & Hers Health Inc has a consensus price target of $28.47 based on the ratings of 20 analysts. The high is $68 issued by Canaccord Genuity on February 19, 2025. The low is $6 issued by Piper Sandler on May 26, 2022. The 3 most-recent analyst ratings were released by B of A Securities, Morgan Stanley, and TD Cowen on April 29, 2025, respectively. With an average price target of $32 between B of A Securities, Morgan Stanley, and TD Cowen, there's an implied -10.36% downside for Hims & Hers Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
1
Jan
2
3
2
Feb
3
Mar
1
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Morgan Stanley
TD Cowen
Citigroup
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Hims & Hers Health

Buy NowGet Alert
04/29/2025Buy Now-27.17%B of A Securities
Allen Lutz57%
$22 → $26MaintainsUnderperformGet Alert
04/29/2025Buy Now12.04%Morgan Stanley
Craig Hettenbach59%
$60 → $40MaintainsEqual-WeightGet Alert
04/29/2025Buy Now-15.97%TD Cowen
Jonna Kim54%
$44 → $30DowngradeBuy → HoldGet Alert
04/25/2025Buy Now-29.97%Citigroup
Daniel Grosslight44%
$27 → $25MaintainsSellGet Alert
04/10/2025Buy Now-7.56%Truist Securities
Jailendra Singh37%
$39 → $33MaintainsHoldGet Alert
03/18/2025Buy Now-38.38%B of A Securities
Allen Lutz57%
$21 → $22MaintainsUnderperformGet Alert
03/06/2025Buy Now-41.18%B of A Securities
Allen Lutz57%
$21 → $21ReiteratesUnderperform → UnderperformGet Alert
03/06/2025Buy Now-24.37%Citigroup
Daniel Grosslight44%
$27 → $27ReiteratesSell → SellGet Alert
02/26/2025Buy Now9.24%Truist Securities
Jailendra Singh37%
$24 → $39MaintainsHoldGet Alert
02/25/2025Buy Now12.04%Leerink Partners
Michael Cherny78%
$24 → $40MaintainsMarket PerformGet Alert
02/25/2025Buy Now-1.96%Piper Sandler
Korinne Wolfmeyer47%
$24 → $35MaintainsNeutralGet Alert
02/25/2025Buy Now70.87%Needham
Ryan MacDonald60%
$31 → $61MaintainsBuyGet Alert
02/25/2025Buy Now-24.37%Citigroup
Daniel Grosslight44%
$25 → $27MaintainsSellGet Alert
02/20/2025Buy Now-41.18%B of A Securities
Allen Lutz57%
$18 → $21MaintainsUnderperformGet Alert
02/19/2025Buy Now90.48%Canaccord Genuity
Maria Ripps72%
$38 → $68MaintainsBuyGet Alert
02/18/2025Buy Now68.07%Morgan Stanley
Craig Hettenbach59%
$42 → $60DowngradeOverweight → Equal-WeightGet Alert
01/10/2025Buy Now-29.97%Citigroup
Daniel Grosslight44%
$24 → $25DowngradeNeutral → SellGet Alert
01/07/2025Buy Now-1.96%BTIG
David Larsen45%
→ $35Initiates → BuyGet Alert
01/06/2025Buy Now-32.77%Piper Sandler
Korinne Wolfmeyer47%
$21 → $24MaintainsNeutralGet Alert
01/06/2025Buy Now-13.17%Needham
Ryan MacDonald60%
$28 → $31MaintainsBuyGet Alert
12/17/2024Buy Now17.65%Morgan Stanley
Craig Hettenbach59%
→ $42Initiates → OverweightGet Alert
12/02/2024Buy Now6.44%Canaccord Genuity
Maria Ripps72%
$28 → $38MaintainsBuyGet Alert
11/20/2024Buy Now-21.57%TD Cowen
Jonna Kim54%
$28 → $28ReiteratesBuy → BuyGet Alert
11/14/2024Buy Now-49.58%B of A Securities
Allen Lutz57%
$32 → $18DowngradeBuy → UnderperformGet Alert
11/08/2024Buy Now-21.57%TD Cowen
Jonna Kim54%
$25 → $28MaintainsBuyGet Alert
11/06/2024Buy Now-24.37%Deutsche Bank
George Hill62%
$23 → $27MaintainsHoldGet Alert
11/05/2024Buy Now-41.18%Piper Sandler
Korinne Wolfmeyer47%
$18 → $21ReiteratesNeutral → NeutralGet Alert
11/05/2024Buy Now-21.57%Canaccord Genuity
Maria Ripps72%
$24 → $28MaintainsBuyGet Alert
10/21/2024Buy Now-29.97%B of A Securities
Michael Cherny78%
$23 → $25MaintainsBuyGet Alert
10/14/2024Buy Now-35.57%B of A Securities
Michael Cherny78%
$20 → $23MaintainsBuyGet Alert
09/13/2024Buy Now-43.98%B of A Securities
Michael Cherny78%
$24 → $20MaintainsBuyGet Alert
08/22/2024Buy Now-32.77%Needham
Ryan MacDonald60%
→ $24Initiates → BuyGet Alert
08/07/2024Buy Now-35.57%Deutsche Bank
George Hill62%
$16 → $23MaintainsHoldGet Alert
08/06/2024Buy Now-49.58%Piper Sandler
Korinne Wolfmeyer47%
$18 → $18ReiteratesNeutral → NeutralGet Alert
07/18/2024Buy Now-35.57%Truist Securities
Jailendra Singh37%
$13 → $23MaintainsHoldGet Alert
07/11/2024Buy Now-29.97%TD Cowen
Jonna Kim54%
$15 → $25MaintainsBuyGet Alert
07/11/2024Buy Now-49.58%Piper Sandler
Korinne Wolfmeyer47%
$16 → $18MaintainsNeutralGet Alert
06/27/2024Buy Now-35.57%Jefferies
Glen Santangelo50%
$14 → $23MaintainsHoldGet Alert
06/13/2024Buy Now-27.17%B of A Securities
Michael Cherny78%
$22 → $26MaintainsBuyGet Alert
06/03/2024Buy Now-38.38%B of A Securities
Michael Cherny78%
$17.25 → $22MaintainsBuyGet Alert
05/22/2024Buy Now-32.77%Canaccord Genuity
Maria Ripps72%
$20 → $24MaintainsBuyGet Alert
05/22/2024Buy Now-43.98%Citigroup
Daniel Grosslight44%
$16 → $20DowngradeBuy → NeutralGet Alert
05/07/2024Buy Now-55.18%Deutsche Bank
George Hill62%
$14 → $16MaintainsHoldGet Alert
05/07/2024Buy Now-63.59%Piper Sandler
Korinne Wolfmeyer47%
$11 → $13MaintainsNeutralGet Alert
04/16/2024Buy Now-57.98%Jefferies
Glen Santangelo50%
$17 → $15DowngradeBuy → HoldGet Alert
04/10/2024Buy Now-43.98%Canaccord Genuity
Maria Ripps72%
→ $20Initiates → BuyGet Alert
02/27/2024Buy Now-52.38%Guggenheim
Jack Wallace57%
$15 → $17MaintainsBuyGet Alert
02/27/2024Buy Now-55.18%Citigroup
Daniel Grosslight44%
$12 → $16MaintainsBuyGet Alert
02/27/2024Buy Now-69.19%Piper Sandler
Michael Lavery66%
$9 → $11MaintainsNeutralGet Alert
02/27/2024Buy Now-63.59%Truist Securities
Jailendra Singh37%
$10 → $13MaintainsHoldGet Alert
02/26/2024Buy Now-71.99%Leerink Partners
Michael Cherny78%
→ $10Initiates → Market PerformGet Alert
01/05/2024Buy Now-57.98%Tigress Financial
Ivan Feinseth72%
$14 → $15MaintainsBuyGet Alert
08/09/2023Buy Now-71.99%Truist Securities
Jailendra Singh37%
$12 → $10MaintainsHoldGet Alert
08/08/2023Buy Now-60.78%Credit Suisse
Jonathan Yong66%
→ $14ReiteratesOutperform → OutperformGet Alert
07/28/2023Buy Now-69.19%TD Cowen
Jonna Kim54%
→ $11Initiates → OutperformGet Alert
06/15/2023Buy Now-60.78%Tigress Financial
Ivan Feinseth72%
$12 → $14Reiterates → BuyGet Alert
05/30/2023Buy Now-69.19%Piper Sandler
Michael Lavery66%
$12 → $11MaintainsNeutralGet Alert
05/09/2023Buy Now-57.98%B of A Securities
Michael Cherny78%
$13.5 → $15MaintainsBuyGet Alert
05/09/2023Buy Now-66.39%Piper Sandler
Michael Lavery66%
$11 → $12MaintainsNeutralGet Alert
04/27/2023Buy Now-49.58%Guggenheim
Jack Wallace57%
$15 → $18MaintainsBuyGet Alert
04/26/2023Buy Now-69.19%Piper Sandler
Korinne Wolfmeyer47%
$10 → $11MaintainsNeutralGet Alert
04/11/2023Buy Now-71.99%Baird
Vikram Kesavabhotla51%
→ $10Initiates → NeutralGet Alert
03/01/2023Buy Now-60.78%Credit Suisse
Jonathan Yong66%
$8 → $14MaintainsOutperformGet Alert
02/28/2023Buy Now-57.98%Guggenheim
Jack Wallace57%
→ $15Reiterates → BuyGet Alert
02/28/2023Buy Now-66.39%Truist Securities
Jailendra Singh37%
$7 → $12MaintainsHoldGet Alert
02/28/2023Buy Now-60.78%Citigroup
Daniel Grosslight44%
$9 → $14MaintainsBuyGet Alert
02/28/2023Buy Now-71.99%Piper Sandler
Korinne Wolfmeyer47%
$7 → $10MaintainsNeutralGet Alert
02/28/2023Buy Now-62.18%B of A Securities
Michael Cherny78%
$11.5 → $13.5MaintainsBuyGet Alert
02/09/2023Buy Now-69.19%Jefferies
Glen Santangelo50%
$7 → $11UpgradeHold → BuyGet Alert
01/12/2023Buy Now-66.39%Tigress Financial
Ivan Feinseth72%
$11 → $12MaintainsBuyGet Alert
11/08/2022Buy Now-76.19%B of A Securities
Michael Cherny78%
$7.5 → $8.5UpgradeNeutral → BuyGet Alert
11/08/2022Buy NowSVB Leerink
Joy Zhang26%
UpgradeUnderperform → Market PerformGet Alert
10/17/2022Buy Now-83.19%Piper Sandler
Korinne Wolfmeyer47%
$8 → $6DowngradeOverweight → NeutralGet Alert
09/07/2022Buy Now-80.39%Truist Securities
Jailendra Singh37%
→ $7Initiates → HoldGet Alert
08/10/2022Buy Now-77.59%Credit Suisse
Jonathan Yong66%
$7 → $8MaintainsOutperformGet Alert
08/09/2022Buy Now-85.99%SVB Leerink
Joy Zhang26%
$4 → $5MaintainsUnderperformGet Alert
07/15/2022Buy Now-88.8%SVB Leerink
Joy Zhang26%
→ $4Initiates → UnderperformGet Alert
05/26/2022Buy Now-83.19%Piper Sandler
Sean Wieland46%
$8 → $6MaintainsOverweightGet Alert
05/10/2022Buy Now-83.19%Citigroup
Daniel Grosslight44%
$9 → $6MaintainsBuyGet Alert

FAQ

Q

What is the target price for Hims & Hers Health (HIMS) stock?

A

The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by B of A Securities on April 29, 2025. The analyst firm set a price target for $26.00 expecting HIMS to fall to within 12 months (a possible -27.17% downside). 44 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE:HIMS) was provided by B of A Securities, and Hims & Hers Health maintained their underperform rating.

Q

When was the last upgrade for Hims & Hers Health (HIMS)?

A

The last upgrade for Hims & Hers Health Inc happened on February 9, 2023 when Jefferies raised their price target to $11. Jefferies previously had a hold for Hims & Hers Health Inc.

Q

When was the last downgrade for Hims & Hers Health (HIMS)?

A

The last downgrade for Hims & Hers Health Inc happened on April 29, 2025 when TD Cowen changed their price target from $44 to $30 for Hims & Hers Health Inc.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $22.00 to $26.00. The current price Hims & Hers Health (HIMS) is trading at is $35.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.